nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0504	0.0644	CbGbCtD
Ramelteon—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0474	0.0606	CbGbCtD
Ramelteon—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0465	0.0594	CbGbCtD
Ramelteon—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0437	0.0559	CbGbCtD
Ramelteon—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0437	0.0559	CbGbCtD
Ramelteon—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0429	0.0548	CbGbCtD
Ramelteon—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0429	0.0548	CbGbCtD
Ramelteon—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0396	0.0505	CbGbCtD
Ramelteon—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.037	0.0473	CbGbCtD
Ramelteon—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0359	0.0459	CbGbCtD
Ramelteon—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0332	0.0423	CbGbCtD
Ramelteon—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0325	0.0415	CbGbCtD
Ramelteon—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0325	0.0415	CbGbCtD
Ramelteon—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0312	0.0398	CbGbCtD
Ramelteon—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.03	0.0383	CbGbCtD
Ramelteon—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0244	0.0311	CbGbCtD
Ramelteon—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0229	0.0293	CbGbCtD
Ramelteon—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0229	0.0293	CbGbCtD
Ramelteon—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0207	0.0265	CbGbCtD
Ramelteon—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0207	0.0265	CbGbCtD
Ramelteon—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0179	0.0229	CbGbCtD
Ramelteon—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0174	0.0222	CbGbCtD
Ramelteon—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0157	0.0201	CbGbCtD
Ramelteon—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0157	0.0201	CbGbCtD
Ramelteon—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0151	0.0192	CbGbCtD
Ramelteon—MTNR1B—retina—acquired immunodeficiency syndrome	0.00731	0.242	CbGeAlD
Ramelteon—MTNR1A—blood—acquired immunodeficiency syndrome	0.00387	0.128	CbGeAlD
Ramelteon—MTNR1A—nervous system—acquired immunodeficiency syndrome	0.00314	0.104	CbGeAlD
Ramelteon—MTNR1A—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00309	0.0598	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00309	0.0598	CbGpPWpGaD
Ramelteon—MTNR1A—central nervous system—acquired immunodeficiency syndrome	0.00302	0.1	CbGeAlD
Ramelteon—Thinking abnormal—Stavudine—acquired immunodeficiency syndrome	0.00283	0.021	CcSEcCtD
Ramelteon—MTNR1A—brain—acquired immunodeficiency syndrome	0.0024	0.0794	CbGeAlD
Ramelteon—Mental disability—Stavudine—acquired immunodeficiency syndrome	0.00225	0.0167	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Didanosine—acquired immunodeficiency syndrome	0.00224	0.0166	CcSEcCtD
Ramelteon—Thinking abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00216	0.016	CcSEcCtD
Ramelteon—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00203	0.0672	CbGeAlD
Ramelteon—Thinking abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00191	0.0142	CcSEcCtD
Ramelteon—Depression—Amprenavir—acquired immunodeficiency syndrome	0.00183	0.0135	CcSEcCtD
Ramelteon—Mental disability—Efavirenz—acquired immunodeficiency syndrome	0.00172	0.0127	CcSEcCtD
Ramelteon—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00166	0.0549	CbGeAlD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00165	0.0318	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00165	0.0318	CbGpPWpGaD
Ramelteon—Mental disability—Delavirdine—acquired immunodeficiency syndrome	0.00164	0.0122	CcSEcCtD
Ramelteon—Influenza—Stavudine—acquired immunodeficiency syndrome	0.00163	0.012	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Indinavir—acquired immunodeficiency syndrome	0.00157	0.0116	CcSEcCtD
Ramelteon—Mental disability—Ritonavir—acquired immunodeficiency syndrome	0.00152	0.0113	CcSEcCtD
Ramelteon—Depression—Stavudine—acquired immunodeficiency syndrome	0.00145	0.0107	CcSEcCtD
Ramelteon—Depression—Abacavir—acquired immunodeficiency syndrome	0.00142	0.0106	CcSEcCtD
Ramelteon—Influenza—Zidovudine—acquired immunodeficiency syndrome	0.00141	0.0105	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00125	0.0242	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00125	0.0242	CbGpPWpGaD
Ramelteon—Upper respiratory tract infection—Indinavir—acquired immunodeficiency syndrome	0.00122	0.00905	CcSEcCtD
Ramelteon—Myalgia—Amprenavir—acquired immunodeficiency syndrome	0.00122	0.00903	CcSEcCtD
Ramelteon—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.0012	0.0397	CbGeAlD
Ramelteon—Influenza—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.0088	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Efavirenz—acquired immunodeficiency syndrome	0.00115	0.00855	CcSEcCtD
Ramelteon—Myalgia—Didanosine—acquired immunodeficiency syndrome	0.00111	0.00823	CcSEcCtD
Ramelteon—Arthralgia—Didanosine—acquired immunodeficiency syndrome	0.00111	0.00823	CcSEcCtD
Ramelteon—Dysgeusia—Stavudine—acquired immunodeficiency syndrome	0.00111	0.00822	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Delavirdine—acquired immunodeficiency syndrome	0.0011	0.00818	CcSEcCtD
Ramelteon—Depression—Efavirenz—acquired immunodeficiency syndrome	0.0011	0.00818	CcSEcCtD
Ramelteon—Influenza—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.00814	CcSEcCtD
Ramelteon—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00107	0.00789	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.00107	0.00789	CcSEcCtD
Ramelteon—Influenza—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00784	CcSEcCtD
Ramelteon—Influenza—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.00748	CcSEcCtD
Ramelteon—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.00101	0.00746	CcSEcCtD
Ramelteon—Myalgia—Nevirapine—acquired immunodeficiency syndrome	0.001	0.0074	CcSEcCtD
Ramelteon—Arthralgia—Nevirapine—acquired immunodeficiency syndrome	0.001	0.0074	CcSEcCtD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000997	0.0193	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000997	0.0193	CbGpPWpGaD
Ramelteon—Upper respiratory tract infection—Saquinavir—acquired immunodeficiency syndrome	0.000983	0.00728	CcSEcCtD
Ramelteon—Depression—Ritonavir—acquired immunodeficiency syndrome	0.000977	0.00724	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.000971	0.00719	CcSEcCtD
Ramelteon—Myalgia—Nelfinavir—acquired immunodeficiency syndrome	0.000968	0.00717	CcSEcCtD
Ramelteon—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.000968	0.00717	CcSEcCtD
Ramelteon—Myalgia—Stavudine—acquired immunodeficiency syndrome	0.000965	0.00715	CcSEcCtD
Ramelteon—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.000965	0.00715	CcSEcCtD
Ramelteon—Dysgeusia—Zidovudine—acquired immunodeficiency syndrome	0.000965	0.00715	CcSEcCtD
Ramelteon—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.000958	0.0071	CcSEcCtD
Ramelteon—Myalgia—Abacavir—acquired immunodeficiency syndrome	0.000951	0.00704	CcSEcCtD
Ramelteon—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.000951	0.00704	CcSEcCtD
Ramelteon—Depression—Saquinavir—acquired immunodeficiency syndrome	0.000941	0.00697	CcSEcCtD
Ramelteon—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.000911	0.00675	CcSEcCtD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000901	0.0174	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000901	0.0174	CbGpPWpGaD
Ramelteon—Depression—Lamivudine—acquired immunodeficiency syndrome	0.000897	0.00665	CcSEcCtD
Ramelteon—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.000897	0.00664	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000873	0.00646	CcSEcCtD
Ramelteon—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000852	0.00631	CcSEcCtD
Ramelteon—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.000848	0.00628	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000845	0.00626	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000843	0.00624	CcSEcCtD
Ramelteon—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000839	0.00622	CcSEcCtD
Ramelteon—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000839	0.00621	CcSEcCtD
Ramelteon—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.000839	0.00621	CcSEcCtD
Ramelteon—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000839	0.00621	CcSEcCtD
Ramelteon—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000837	0.0062	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00083	0.00615	CcSEcCtD
Ramelteon—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000826	0.00612	CcSEcCtD
Ramelteon—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000825	0.00611	CcSEcCtD
Ramelteon—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000824	0.0061	CcSEcCtD
Ramelteon—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000822	0.00609	CcSEcCtD
Ramelteon—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.000811	0.00601	CcSEcCtD
Ramelteon—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000804	0.00595	CcSEcCtD
Ramelteon—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.0008	0.00592	CcSEcCtD
Ramelteon—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000798	0.00591	CcSEcCtD
Ramelteon—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000786	0.00582	CcSEcCtD
Ramelteon—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000781	0.0258	CbGeAlD
Ramelteon—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.00078	0.00578	CcSEcCtD
Ramelteon—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00078	0.00578	CcSEcCtD
Ramelteon—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000765	0.00566	CcSEcCtD
Ramelteon—MTNR1A—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000759	0.0147	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000759	0.0147	CbGpPWpGaD
Ramelteon—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00075	0.00555	CcSEcCtD
Ramelteon—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000748	0.00554	CcSEcCtD
Ramelteon—CYP2C19—blood—acquired immunodeficiency syndrome	0.000744	0.0246	CbGeAlD
Ramelteon—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000737	0.00546	CcSEcCtD
Ramelteon—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000737	0.00546	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000733	0.00543	CcSEcCtD
Ramelteon—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000732	0.00542	CcSEcCtD
Ramelteon—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000729	0.0054	CcSEcCtD
Ramelteon—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000727	0.00539	CcSEcCtD
Ramelteon—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000722	0.00535	CcSEcCtD
Ramelteon—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000715	0.00529	CcSEcCtD
Ramelteon—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000705	0.00522	CcSEcCtD
Ramelteon—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000705	0.00522	CcSEcCtD
Ramelteon—MTNR1A—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.0007	0.0135	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.0007	0.0135	CbGpPWpGaD
Ramelteon—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000694	0.00514	CcSEcCtD
Ramelteon—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000693	0.00513	CcSEcCtD
Ramelteon—CYP2C19—vagina—acquired immunodeficiency syndrome	0.00069	0.0228	CbGeAlD
Ramelteon—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000689	0.0051	CcSEcCtD
Ramelteon—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000687	0.00509	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000686	0.0133	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000686	0.0133	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000681	0.00505	CcSEcCtD
Ramelteon—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000676	0.00501	CcSEcCtD
Ramelteon—Headache—Didanosine—acquired immunodeficiency syndrome	0.000668	0.00494	CcSEcCtD
Ramelteon—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000666	0.00493	CcSEcCtD
Ramelteon—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000665	0.00492	CcSEcCtD
Ramelteon—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000664	0.00492	CcSEcCtD
Ramelteon—MTNR1A—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000659	0.0127	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000659	0.0127	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000659	0.0127	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000659	0.0127	CbGpPWpGaD
Ramelteon—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000656	0.00485	CcSEcCtD
Ramelteon—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000654	0.00484	CcSEcCtD
Ramelteon—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000652	0.00483	CcSEcCtD
Ramelteon—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000652	0.00483	CcSEcCtD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00065	0.0126	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00065	0.0126	CbGpPWpGaD
Ramelteon—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000645	0.00477	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000644	0.00477	CcSEcCtD
Ramelteon—MTNR1A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000643	0.0124	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000643	0.0124	CbGpPWpGaD
Ramelteon—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000639	0.00473	CcSEcCtD
Ramelteon—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000638	0.0211	CbGeAlD
Ramelteon—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000635	0.0047	CcSEcCtD
Ramelteon—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000633	0.00469	CcSEcCtD
Ramelteon—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000633	0.00469	CcSEcCtD
Ramelteon—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000628	0.00465	CcSEcCtD
Ramelteon—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000628	0.00465	CcSEcCtD
Ramelteon—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000628	0.00465	CcSEcCtD
Ramelteon—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000624	0.00462	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000616	0.00456	CcSEcCtD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000616	0.0119	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000616	0.0119	CbGpPWpGaD
Ramelteon—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000614	0.00454	CcSEcCtD
Ramelteon—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000612	0.00453	CcSEcCtD
Ramelteon—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000611	0.00453	CcSEcCtD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000611	0.0118	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000611	0.0118	CbGpPWpGaD
Ramelteon—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000609	0.00451	CcSEcCtD
Ramelteon—CYP1A2—blood—acquired immunodeficiency syndrome	0.000608	0.0201	CbGeAlD
Ramelteon—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000603	0.00446	CcSEcCtD
Ramelteon—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000601	0.00445	CcSEcCtD
Ramelteon—Headache—Nevirapine—acquired immunodeficiency syndrome	0.0006	0.00445	CcSEcCtD
Ramelteon—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000599	0.00443	CcSEcCtD
Ramelteon—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000599	0.00443	CcSEcCtD
Ramelteon—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000583	0.00432	CcSEcCtD
Ramelteon—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000581	0.00431	CcSEcCtD
Ramelteon—Headache—Stavudine—acquired immunodeficiency syndrome	0.00058	0.00429	CcSEcCtD
Ramelteon—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000577	0.00427	CcSEcCtD
Ramelteon—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000574	0.00425	CcSEcCtD
Ramelteon—Headache—Abacavir—acquired immunodeficiency syndrome	0.000571	0.00423	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00057	0.00422	CcSEcCtD
Ramelteon—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000569	0.00421	CcSEcCtD
Ramelteon—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000565	0.00419	CcSEcCtD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000557	0.0108	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000557	0.0108	CbGpPWpGaD
Ramelteon—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000556	0.00412	CcSEcCtD
Ramelteon—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000551	0.00408	CcSEcCtD
Ramelteon—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00055	0.00407	CcSEcCtD
Ramelteon—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00055	0.00407	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000548	0.00406	CcSEcCtD
Ramelteon—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000544	0.00403	CcSEcCtD
Ramelteon—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000541	0.00401	CcSEcCtD
Ramelteon—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000539	0.00399	CcSEcCtD
Ramelteon—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000537	0.00397	CcSEcCtD
Ramelteon—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000535	0.00396	CcSEcCtD
Ramelteon—CYP1A2—lung—acquired immunodeficiency syndrome	0.000533	0.0176	CbGeAlD
Ramelteon—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000532	0.00394	CcSEcCtD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000524	0.0101	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000524	0.0101	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000524	0.0101	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000524	0.0101	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000523	0.00387	CcSEcCtD
Ramelteon—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000519	0.00384	CcSEcCtD
Ramelteon—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000519	0.00384	CcSEcCtD
Ramelteon—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000512	0.00379	CcSEcCtD
Ramelteon—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00051	0.00378	CcSEcCtD
Ramelteon—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000507	0.00375	CcSEcCtD
Ramelteon—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000504	0.00373	CcSEcCtD
Ramelteon—MTNR1B—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000501	0.00968	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000501	0.00968	CbGpPWpGaD
Ramelteon—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000495	0.00366	CcSEcCtD
Ramelteon—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000495	0.00366	CcSEcCtD
Ramelteon—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000485	0.00359	CcSEcCtD
Ramelteon—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000483	0.00358	CcSEcCtD
Ramelteon—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000478	0.00354	CcSEcCtD
Ramelteon—MTNR1A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000469	0.00906	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000469	0.00906	CbGpPWpGaD
Ramelteon—Headache—Indinavir—acquired immunodeficiency syndrome	0.000468	0.00347	CcSEcCtD
Ramelteon—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000467	0.00346	CcSEcCtD
Ramelteon—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000463	0.00343	CcSEcCtD
Ramelteon—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000462	0.0153	CbGeAlD
Ramelteon—MTNR1A—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000451	0.00872	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000451	0.00872	CbGpPWpGaD
Ramelteon—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000449	0.00332	CcSEcCtD
Ramelteon—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000447	0.00331	CcSEcCtD
Ramelteon—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000444	0.00329	CcSEcCtD
Ramelteon—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000443	0.00328	CcSEcCtD
Ramelteon—CYP3A4—blood—acquired immunodeficiency syndrome	0.00044	0.0145	CbGeAlD
Ramelteon—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000432	0.0032	CcSEcCtD
Ramelteon—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000428	0.00317	CcSEcCtD
Ramelteon—MTNR1A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000424	0.0082	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000424	0.0082	CbGpPWpGaD
Ramelteon—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000424	0.00314	CcSEcCtD
Ramelteon—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.00311	CcSEcCtD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000419	0.0081	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000419	0.0081	CbGpPWpGaD
Ramelteon—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000413	0.00306	CcSEcCtD
Ramelteon—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000412	0.00305	CcSEcCtD
Ramelteon—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000412	0.00305	CcSEcCtD
Ramelteon—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000402	0.00297	CcSEcCtD
Ramelteon—MTNR1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000399	0.00771	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000399	0.00771	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000399	0.00771	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000399	0.00771	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000398	0.0077	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000398	0.0077	CbGpPWpGaD
Ramelteon—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000398	0.00295	CcSEcCtD
Ramelteon—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000393	0.00291	CcSEcCtD
Ramelteon—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000392	0.0029	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00039	0.00753	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00039	0.00753	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00038	0.00734	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00038	0.00734	CbGpPWpGaD
Ramelteon—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00038	0.00281	CcSEcCtD
Ramelteon—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000377	0.00279	CcSEcCtD
Ramelteon—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00275	CcSEcCtD
Ramelteon—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00036	0.00266	CcSEcCtD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000359	0.00694	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000359	0.00694	CbGpPWpGaD
Ramelteon—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00265	CcSEcCtD
Ramelteon—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000357	0.0118	CbGeAlD
Ramelteon—MTNR1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000352	0.00681	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000352	0.00681	CbGpPWpGaD
Ramelteon—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000344	0.0114	CbGeAlD
Ramelteon—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.00252	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000303	0.00586	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000303	0.00586	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000273	0.00528	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000273	0.00528	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000241	0.00465	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000241	0.00465	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00024	0.00463	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00024	0.00463	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00023	0.00445	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00023	0.00445	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00023	0.00445	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00023	0.00445	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000225	0.00435	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000225	0.00435	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000225	0.00435	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000225	0.00435	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000218	0.00421	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000218	0.00421	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000208	0.00402	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000208	0.00402	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000205	0.00395	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000205	0.00395	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000205	0.00395	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000205	0.00395	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000174	0.00336	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000174	0.00336	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000171	0.00331	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000171	0.00331	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000169	0.00326	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000169	0.00326	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000156	0.00301	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000156	0.00301	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000154	0.00298	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000154	0.00298	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000153	0.00296	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000153	0.00296	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000142	0.00275	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000142	0.00275	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00014	0.00271	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00014	0.00271	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000129	0.00248	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000129	0.00248	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000123	0.00238	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000121	0.00234	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000121	0.00234	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000121	0.00234	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000121	0.00234	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000113	0.00218	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000109	0.00211	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.2e-05	0.00178	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.2e-05	0.00178	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.06e-05	0.00175	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.06e-05	0.00175	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.92e-05	0.00172	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.92e-05	0.00172	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.78e-05	0.0017	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.28e-05	0.0016	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.28e-05	0.0016	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.1e-05	0.00157	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.1e-05	0.00157	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	7.95e-05	0.00154	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	7.95e-05	0.00154	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	5.9e-05	0.00114	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	5.02e-05	0.00097	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.79e-05	0.000925	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.79e-05	0.000925	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.76e-05	0.000921	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.76e-05	0.000921	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	4.6e-05	0.000889	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.91e-05	0.000756	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	3.55e-05	0.000686	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	3.02e-05	0.000583	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.81e-05	0.000544	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.81e-05	0.000544	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.31e-05	0.000447	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.8e-05	0.000348	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	1.03e-05	0.000199	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	8.02e-06	0.000155	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	6.19e-06	0.00012	CbGpPWpGaD
